An anti-tumor coup: TIM3 ablation activates the immune arsenal.
Signal Transduct Target Ther
2021
6
1
Deletion of pancreas-specific miR-216a reduces beta-cell mass and inhibits pancreatic cancer progression in mice.
Cell Rep Med
2021
2
11
Correction: Identification of risk factors for post-endoscopic retrograde cholangiopancreatography pancreatitis in a high volume center.
PLoS ONE
2021
16
12
AGR2-Dependent Nuclear Import of RNA Polymerase II Constitutes a Specific Target of Pancreatic Ductal Adenocarcinoma in the Context of Wild-Type p53.
Gastroenterology
2021
161
5
1601-1614.e23
A Pancreas-Specific Ptf1a-Driven Cre Mouse Line Causes Paternally Transmitted Germline Recombination.
Gastroenterology
2021
161
5
1695-1697.e4
Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial.
Lancet Gastroenterol Hepatol
2021
6
2
128-138
Bcl3 Couples Cancer Stem Cell Enrichment With Pancreatic Cancer Molecular Subtypes.
Gastroenterology
2021
161
1
318-332.e9
PALLD mutation in a European family conveys a stromal predisposition for familial pancreatic cancer.
JCI Insight
2021
6
8